ClearPoint Neuro, Inc. provided revenue guidance for the year of 2022. The company estimated revenue in 2022 to be between $20.0 and $22.0 million, representing growth between 23% and 35%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.94 USD | +1.19% | +11.44% | -12.52% |
30/04 | Clinical Laserthermia Notes US FDA Clearance for ClearPoint's Prism Bone Anchor Accessory | MT |
29/04 | ClearPoint Gets FDA Clearance For Neurosurgical Equipment | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.52% | 161M | |
+8.06% | 219B | |
+6.94% | 183B | |
+13.54% | 136B | |
-3.92% | 63.07B | |
+11.59% | 51.28B | |
+7.76% | 52.55B | |
+1.14% | 41.21B | |
+3.21% | 36.43B | |
+26.11% | 31.87B |
- Stock Market
- Equities
- CLPT Stock
- News ClearPoint Neuro, Inc.
- ClearPoint Neuro, Inc. Provides Revenue Guidance for the Year of 2022